YAP/TAZ-mediated upregulation of GAB2 leads to increased sensitivity to growth factor-induced activation of the PI3K pathway

Chao Wang, Chao Gu, Kang Jin Jeong, Dong Zhang, Wei Guo, Yiling Lu, Zhenlin Ju, Nattapon Panupinthu, Ji Yeon Yang, Mihai Mike Gagea, Patrick Kwok Shing Ng, Fan Zhang, Gordon Mills

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The transcription regulators YAP and TAZ function as effectors of the HIPPO signaling cascade, critical for organismal development, cell growth, and cellular reprogramming, and YAP/TAZ is commonly misregulated in human cancers. The precise mechanism by which aberrant YAP/TAZ promotes tumor growth remains unclear. The HIPPO tumor suppressor pathway phosphorylates YAP and TAZ, resulting in cytosolic sequestration with subsequent degradation. Here, we report that the PI3K/AKT pathway, which is critically involved in the pathophysiology of endometrial cancer, interacts with the HIPPO pathway at multiple levels. Strikingly, coordinate knockdown of YAP and TAZ, mimicking activation of the HIPPO pathway, markedly decreased both constitutive and growth factor-induced PI3K pathway activation by decreasing levels of the GAB2 linker molecule in endometrial cancer lines. Furthermore, targeting YAP/TAZ decreased endometrial cancer tumor growth in vivo. In addition, YAP and TAZ total and phosphoprotein levels correlated with clinical characteristics and outcomes in endometrial cancer. Thus, YAP and TAZ, which are inhibited by the HIPPO tumor suppressor pathway, modify PI3K/AKT pathway signaling in endometrial cancer. The cross-talk between these key pathways identifies potential new biomarkers and therapeutic targets in endometrial cancer.

Original languageEnglish (US)
Pages (from-to)1637-1648
Number of pages12
JournalCancer Research
Volume77
Issue number7
DOIs
StatePublished - Jan 1 2017
Externally publishedYes

Fingerprint

Endometrial Neoplasms
Phosphatidylinositol 3-Kinases
Intercellular Signaling Peptides and Proteins
Up-Regulation
Neoplasms
Phosphoproteins
Growth
Growth and Development
Biomarkers

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

YAP/TAZ-mediated upregulation of GAB2 leads to increased sensitivity to growth factor-induced activation of the PI3K pathway. / Wang, Chao; Gu, Chao; Jeong, Kang Jin; Zhang, Dong; Guo, Wei; Lu, Yiling; Ju, Zhenlin; Panupinthu, Nattapon; Yang, Ji Yeon; Gagea, Mihai Mike; Ng, Patrick Kwok Shing; Zhang, Fan; Mills, Gordon.

In: Cancer Research, Vol. 77, No. 7, 01.01.2017, p. 1637-1648.

Research output: Contribution to journalArticle

Wang, C, Gu, C, Jeong, KJ, Zhang, D, Guo, W, Lu, Y, Ju, Z, Panupinthu, N, Yang, JY, Gagea, MM, Ng, PKS, Zhang, F & Mills, G 2017, 'YAP/TAZ-mediated upregulation of GAB2 leads to increased sensitivity to growth factor-induced activation of the PI3K pathway', Cancer Research, vol. 77, no. 7, pp. 1637-1648. https://doi.org/10.1158/0008-5472.CAN-15-3084
Wang, Chao ; Gu, Chao ; Jeong, Kang Jin ; Zhang, Dong ; Guo, Wei ; Lu, Yiling ; Ju, Zhenlin ; Panupinthu, Nattapon ; Yang, Ji Yeon ; Gagea, Mihai Mike ; Ng, Patrick Kwok Shing ; Zhang, Fan ; Mills, Gordon. / YAP/TAZ-mediated upregulation of GAB2 leads to increased sensitivity to growth factor-induced activation of the PI3K pathway. In: Cancer Research. 2017 ; Vol. 77, No. 7. pp. 1637-1648.
@article{1d4c6e42691b4abb9e97cbc193c019c8,
title = "YAP/TAZ-mediated upregulation of GAB2 leads to increased sensitivity to growth factor-induced activation of the PI3K pathway",
abstract = "The transcription regulators YAP and TAZ function as effectors of the HIPPO signaling cascade, critical for organismal development, cell growth, and cellular reprogramming, and YAP/TAZ is commonly misregulated in human cancers. The precise mechanism by which aberrant YAP/TAZ promotes tumor growth remains unclear. The HIPPO tumor suppressor pathway phosphorylates YAP and TAZ, resulting in cytosolic sequestration with subsequent degradation. Here, we report that the PI3K/AKT pathway, which is critically involved in the pathophysiology of endometrial cancer, interacts with the HIPPO pathway at multiple levels. Strikingly, coordinate knockdown of YAP and TAZ, mimicking activation of the HIPPO pathway, markedly decreased both constitutive and growth factor-induced PI3K pathway activation by decreasing levels of the GAB2 linker molecule in endometrial cancer lines. Furthermore, targeting YAP/TAZ decreased endometrial cancer tumor growth in vivo. In addition, YAP and TAZ total and phosphoprotein levels correlated with clinical characteristics and outcomes in endometrial cancer. Thus, YAP and TAZ, which are inhibited by the HIPPO tumor suppressor pathway, modify PI3K/AKT pathway signaling in endometrial cancer. The cross-talk between these key pathways identifies potential new biomarkers and therapeutic targets in endometrial cancer.",
author = "Chao Wang and Chao Gu and Jeong, {Kang Jin} and Dong Zhang and Wei Guo and Yiling Lu and Zhenlin Ju and Nattapon Panupinthu and Yang, {Ji Yeon} and Gagea, {Mihai Mike} and Ng, {Patrick Kwok Shing} and Fan Zhang and Gordon Mills",
year = "2017",
month = "1",
day = "1",
doi = "10.1158/0008-5472.CAN-15-3084",
language = "English (US)",
volume = "77",
pages = "1637--1648",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "7",

}

TY - JOUR

T1 - YAP/TAZ-mediated upregulation of GAB2 leads to increased sensitivity to growth factor-induced activation of the PI3K pathway

AU - Wang, Chao

AU - Gu, Chao

AU - Jeong, Kang Jin

AU - Zhang, Dong

AU - Guo, Wei

AU - Lu, Yiling

AU - Ju, Zhenlin

AU - Panupinthu, Nattapon

AU - Yang, Ji Yeon

AU - Gagea, Mihai Mike

AU - Ng, Patrick Kwok Shing

AU - Zhang, Fan

AU - Mills, Gordon

PY - 2017/1/1

Y1 - 2017/1/1

N2 - The transcription regulators YAP and TAZ function as effectors of the HIPPO signaling cascade, critical for organismal development, cell growth, and cellular reprogramming, and YAP/TAZ is commonly misregulated in human cancers. The precise mechanism by which aberrant YAP/TAZ promotes tumor growth remains unclear. The HIPPO tumor suppressor pathway phosphorylates YAP and TAZ, resulting in cytosolic sequestration with subsequent degradation. Here, we report that the PI3K/AKT pathway, which is critically involved in the pathophysiology of endometrial cancer, interacts with the HIPPO pathway at multiple levels. Strikingly, coordinate knockdown of YAP and TAZ, mimicking activation of the HIPPO pathway, markedly decreased both constitutive and growth factor-induced PI3K pathway activation by decreasing levels of the GAB2 linker molecule in endometrial cancer lines. Furthermore, targeting YAP/TAZ decreased endometrial cancer tumor growth in vivo. In addition, YAP and TAZ total and phosphoprotein levels correlated with clinical characteristics and outcomes in endometrial cancer. Thus, YAP and TAZ, which are inhibited by the HIPPO tumor suppressor pathway, modify PI3K/AKT pathway signaling in endometrial cancer. The cross-talk between these key pathways identifies potential new biomarkers and therapeutic targets in endometrial cancer.

AB - The transcription regulators YAP and TAZ function as effectors of the HIPPO signaling cascade, critical for organismal development, cell growth, and cellular reprogramming, and YAP/TAZ is commonly misregulated in human cancers. The precise mechanism by which aberrant YAP/TAZ promotes tumor growth remains unclear. The HIPPO tumor suppressor pathway phosphorylates YAP and TAZ, resulting in cytosolic sequestration with subsequent degradation. Here, we report that the PI3K/AKT pathway, which is critically involved in the pathophysiology of endometrial cancer, interacts with the HIPPO pathway at multiple levels. Strikingly, coordinate knockdown of YAP and TAZ, mimicking activation of the HIPPO pathway, markedly decreased both constitutive and growth factor-induced PI3K pathway activation by decreasing levels of the GAB2 linker molecule in endometrial cancer lines. Furthermore, targeting YAP/TAZ decreased endometrial cancer tumor growth in vivo. In addition, YAP and TAZ total and phosphoprotein levels correlated with clinical characteristics and outcomes in endometrial cancer. Thus, YAP and TAZ, which are inhibited by the HIPPO tumor suppressor pathway, modify PI3K/AKT pathway signaling in endometrial cancer. The cross-talk between these key pathways identifies potential new biomarkers and therapeutic targets in endometrial cancer.

UR - http://www.scopus.com/inward/record.url?scp=85017360608&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017360608&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-15-3084

DO - 10.1158/0008-5472.CAN-15-3084

M3 - Article

VL - 77

SP - 1637

EP - 1648

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 7

ER -